P/Q-type Ca2+ channel blocker ω-agatoxin IVA protects against brain injury after focal ischemia in rats

Brain Research

Volumn 776, Issue 1-2, 1997, Pages 140-145

  Asakura, Kenji ^a   Matsuo, Yoshiyuki ^a   Kanemasa, Toshiyuki ^a   Ninomiya, Mitsuyoshi ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Agatoxin IVA; Brain edema; Focal ischemia; Infarct size; Neuroprotection; P Q type Ca2+ channel

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; OMEGA AGATOXIN IVA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BODY TEMPERATURE; BRAIN EDEMA; CALCIUM CHANNEL BLOCKERS; CEREBRAL INFARCTION; CONSCIOUSNESS; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; OMEGA-AGATOXIN IVA; RATS; RATS, WISTAR; REPERFUSION INJURY; SPIDER VENOMS;

EID: 0031446197     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00975-X     Document Type: Article

References (34)

1. Attwell D., Barbour B., Szatkowski M. Non-vesicular release of neurotransmitter. Neuron. 11:1993;401-407.
2. Benveniste H., Drejer J., Diemer H.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
3. 2+ channel blocker prevents CA1 injury 24 h following focal ischemia. J. Cereb. Blood Flow Metab. 14:1994;903-910.
4. Busto R., Dietrich W.D., Globus M.Y.-Y., Valdes I., Scheinberg P., Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J. Cereb. Blood Flow Metab. 7:1987;729-738.
5. Butcher S.P., Bullock R., Graham D.I., McCulloch J. Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke. 21:1990;1727-1733.
6. Chen H., Chopp M., Zhang Z.G., Garcia J.H. The effect of hypothermia on transient middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12:1992;621-628.
7. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
8. 2+ channels in mammalian central neurons. Trends Neurosci. 18:1995;89-98.
9. Gemba T., Oshima T., Ninomiya M. Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience. 63:1994;789-795.
10. Hillered L., Hallstrom A., Segersaard S., Persson L., Ungerstedt U. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J. Cereb. Blood Flow Metab. 9:1989;607-616.
11. 2+ channels mediate excitatory and inhibitory synaptic transmitter release in crayfish muscle. Proc. Natl. Acad. Sci. USA. 91:1994;4224-4228.
12. 2+ channels by two mechanisms. Brain Res. 702:1995;207-212.
13. Katayama Y., Kawamata T., Tamura T., Hovda D.A., Becker D.P., Tsubokawa T. Calcium-dependent glutamate release concomitant with massive potassium flux during cerebral ischemia in vivo. Brain Res. 558:1991;136-140.
14. Leubke J.I., Dunlap K., Turner T.J. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron. 11:1993;895-902.
15. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
16. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: effects of neutrophil depletion. Stroke. 25:1994;1469-1475.
17. Mintz I.M., Venema V.J., Swiderek K.M., Lee T.D., Bean B.P., Adams M.E. P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature. 355:1992;827-829.
18. Mintz I.M., Adams M.E., Bean B.P. P-type calcium channels in rat central and peripheral neurons. Neuron. 9:1992;85-89.
19. Momiyama A., Takahashi T. Calcium channels responsible for potassium-induced transmitter release at rat cerebellar synapse. J. Physiol. 476:1994;197-202.
20. Morikawa E., Ginsenberg M.D., Dietrich W.D., Duncan R.C., Kraydieh S., Globus M.Y.-T., Busto R. The significance of brain temperature in focal cerebral ischemia: histopathological consequences of mild cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 12:1992;380-389.
21. Mulkey R.M., Zucker R.S. Action potential must admit calcium to evoke transmitter release. Nature. 350:1991;153-155.
22. Nishio H., Yoshizawa K., Kubo S., Chen Y., Momiyama A., Takahashi T., Kimura T., Sakakibara S. Synthesis of ω-Agatoxin IVA and its related peptides. Biochem. Biophys. Res. Commun. 196:1993;1447-1453.
23. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 15:1995;2995-3012.
24. Sanguinetti M.C., Kass R.S. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihidropyridine calcium channel antagonists. Circ. Res. 55:1984;336-348.
25. Simon R.P., Swan J.H., Griffiths T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
26. Syunya T., Matsushima K., Fujita H., Nanri K., Ogawa S., Shinohara Y. A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;611-618.
27. Turner T., Adams M.E., Dunlap K. Calcium channels coupled to glutamate release identified by ω-Aga-IVA. Science. 258:1992;310-313.
28. Turner T.J., Dunlap K. Pharmacological characterization of presynaptic calcium channels using subsecond biochemical measurements of synaptosomal neurosecretion. Neuropharmacology. 34(11):1995;1469-1478.
29. 2+ channels in supporting hippocampal synaptic transmission. Science. 264:1994;107-111.
30. Wu G., Kim H.K., Zornow M.H. Transient brain ischemia in rabbits: the effect of ω-conopeptide MVIIC on hippocampal excitatory amino acids. Brain Res. 692:1995;118-122.
31. Yamada K., Teraoka T., Hasegawa T., Nabeshima T. ω-Conotoxin GVIA protects against ischemia-induced neuronal death in the Mongolian gerbil but not against quinolinic acid-induced neurotoxicity in the rat. Neuropharmacology. 33:1994;251-254.
32. Yenari M.A., Palmer J., Sun G.H., de Crespigny A., Moseley M.E., Steinberg G.K. Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI. Brain Res. 739:1996;36-45.
33. Zhao Q., Smith M.-L., Siesjö B.K. The ω-conopeptide, SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischemia. Acta Physiol. Scand. 150:1994;459-461.
34. 2+ channels and their possible counterparts in mammalian CNS neuron. Neuropharmacology. 32:1993;1075-1088.